FERRARO, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 420
EU - Europa 276
AS - Asia 169
AF - Africa 11
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 880
Nazione #
US - Stati Uniti d'America 400
IT - Italia 212
SG - Singapore 96
VN - Vietnam 36
CN - Cina 30
NL - Olanda 21
CA - Canada 20
DE - Germania 14
CI - Costa d'Avorio 11
FI - Finlandia 8
FR - Francia 6
GB - Regno Unito 5
CY - Cipro 4
BE - Belgio 2
BR - Brasile 2
IE - Irlanda 2
IN - India 2
SE - Svezia 2
UA - Ucraina 2
AR - Argentina 1
BG - Bulgaria 1
EU - Europa 1
PK - Pakistan 1
PT - Portogallo 1
Totale 880
Città #
Chandler 95
Singapore 78
Naples 53
Ashburn 48
Dong Ket 36
Santa Clara 25
Amsterdam 20
Napoli 20
Lawrence 18
Ottawa 18
Millbury 16
Milan 14
Beijing 13
Des Moines 12
Mugnano di Napoli 11
Boston 9
Cava de' Tirreni 7
Lappeenranta 7
Salerno 7
Wilmington 5
Florence 4
Kronberg 4
Limassol 4
Nanjing 4
Seattle 4
Selargius 4
Torre Annunziata 4
Aprilia 3
Edinburgh 3
Fairfield 3
Menlo Park 3
Modena 3
Reggio Calabria 3
Trento 3
Bari 2
Casavatore 2
Chengdu 2
Dublin 2
Ercolano 2
Forlì 2
Houston 2
Pisa 2
Pune 2
Recife 2
Redwood City 2
Vietri sul Mare 2
Woodbridge 2
Wuhan 2
Acton 1
Afragola 1
Agropoli 1
Aveiro 1
Aversa 1
Brussels 1
Capua 1
Caserta 1
Centrale 1
Cercola 1
Cinisello Balsamo 1
Dallas 1
Frankfurt am Main 1
Fremont 1
Gessate 1
Giugliano in Campania 1
Giungano 1
Gragnano 1
Guangzhou 1
Gunzenhausen 1
Hassan Abdal 1
Helsinki 1
Irpin 1
Krefeld 1
Lioni 1
Liège 1
Marseille 1
Nagold 1
Nanaimo 1
Paris 1
Poli 1
Quartu Sant'elena 1
Rome 1
Rosario 1
San Francisco 1
Shenzhen 1
Somma Vesuviana 1
Springfield 1
Toronto 1
Udine 1
Verdellino 1
Verona 1
Worcester 1
Totale 632
Nome #
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 67
Promelanogenic Effects by an Annurca Apple-Based Natural Formulation in Human Primary Melanocytes 59
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 54
Breast cancer chemotherapeutic options: a general overview on the preclinical validation of a multi-target ruthenium(III) complex lodged in nucleolipid nanosystems 50
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 44
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 44
Prolonged activity of a recombinant manganese superoxide dismutase through a formulation of polymeric multi-layer nanoassemblies targeting cancer cells 44
Nucleolipidic-based Ru(III) nanosystems induce multiple cell death pathways activation in preclinical models of human breast cancer 42
Induction of hair keratins expression by an Annurca Apple-based nutraceutical formulation in human follicular cells 41
Exploring cellular uptake, accumulation and mechanism of action of an anticancer Ru(III) complex loaded into a nucleolipidic-based nanosystem in preclinical models of human breast cancer 40
Preclinical evaluation of Tanshinones from Salvia miltiorrhiza Bunge on human glioblastoma models in vitro 40
Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of Alzheimer 35
Bovine herpesvirus-1 infection in mouse neuroblastoma (Neuro-2A) cells 33
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders 32
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 32
Lipophilicity profiling and cell viability assessment of a selected panel of endocrine disruptors 25
MG-132 interferes with iron cellular homeostasis and alters virulence of bovine herpesvirus 1 24
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 24
Tetrasubstituted Pyrrole Derivative Mimetics of Protein–Protein Interaction Hot-Spot Residues: A Promising Class of Anticancer Agents Targeting Melanoma Cells 22
Coupling Interrupted Fischer and Multicomponent Joullié-Ugi to Chase Chemical Diversity: from Batch to Sustainable Flow Synthesis of Peptidomimetics 22
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 21
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 21
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 20
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 20
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 18
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 18
Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches 17
Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer 15
Enduring Neurobiological Consequences of Early-Life Stress: Insights from Rodent Behavioral Paradigms 15
Antiviral activity of Taurisolo® during bovine alphaherpesvirus 1 infection 14
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 8
Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies 6
Totale 967
Categoria #
all - tutte 5.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 15 1 7 1 3 7 13 11
2020/2021105 11 8 4 3 4 11 5 1 6 10 2 40
2021/2022123 3 0 6 1 5 7 4 2 10 18 25 42
2022/2023267 20 21 9 8 35 23 13 36 54 21 18 9
2023/2024215 9 22 33 18 12 16 17 24 5 14 16 29
2024/2025190 59 56 14 37 24 0 0 0 0 0 0 0
Totale 967